ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Dichloromethane → 4-(2-chloro-9-methyl-6-morpholin-4-yl-9H-purin-8-yl)piperidine-1-carboxylic acid tert-butyl ester

HRID 1923289
印刷

反応式

HRID 1923289 の反応式
BrCCBr.[C:5]([O:9][C:10]([N:12]1[CH2:17][CH2:16][CH:15](I)[CH2:14][CH2:13]1)=[O:11])([CH3:8])([CH3:7])[CH3:6].[Cl:19][C:20]1[N:28]=[C:27]2[C:23]([N:24]=[C:25](I)[N:26]2[CH3:29])=[C:22]([N:31]2[CH2:36][CH2:35][O:34][CH2:33][CH2:32]2)[N:21]=1.C(Cl)Cl>CC(N(C)C)=O.[Zn].C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2].[Cu]I>[C:5]([O:9][C:10]([N:12]1[CH2:17][CH2:16][CH:15]([C:25]2[N:26]([CH3:29])[C:27]3[C:23]([N:24]=2)=[C:22]([N:31]2[CH2:36][CH2:35][O:34][CH2:33][CH2:32]2)[N:21]=[C:20]([Cl:19])[N:28]=3)[CH2:14][CH2:13]1)=[O:11])([CH3:8])([CH3:7])[CH3:6]
参加物実験手順後処理出典と根拠反応ノート

参加物

9

反応物 4

HCID 6344Dichloromethane2 回HCID 78391,2-DibromoethaneHCID 10892302Tert-butyl 4-iodopiperidine-1-carboxylateHCID 596059622-Chloro-8-iodo-9-methyl-6-morpholin-4-yl-9H-purine

生成物 1

HCID 596059154-(2-chloro-9-methyl-6-morpholin-4-yl-9H-purin-8-yl)piperidine-1-carboxylic acid tert-butyl ester収率 33%

試薬・触媒・溶媒

4
HCID 23994Zinc触媒HCID 24350Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)触媒2 回HCID 44119782Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+)触媒2 回HCID 31374Dimethylacetamide溶媒2 回

実験手順

To a suspension of zinc powder (320 mg, 4.92 mmol) and Celpure P65 in anhydrous DMA (3 mL) was added a 7:5 (v:v) mixture of TMS-C1:1,2-dibromoethane (65 μL) drop wise. The reaction mixture was stirred at room temperature for 15 min. A solution of 4-iodopiperidine-1-carboxylic acid tert-butyl ester (1.22 g, 3.95 mmol) in anhydrous DMA (2 mL) was added dropwise to the mixture described above and the reaction mixture was stirred for 30 minutes at room temperature. The zincate mixture was quickly filtered through a grade-3 sintered funnel and added onto a mixture of 2-Chloro-8-iodo-9-methyl-6-morpholin-4-yl-9H-purine (1.0 g, 2.63 mmol), Pd(dppf)Cl2.DCM (107 mg, 0.13 mmol) and CuI (50 mg, 0.26 mmol). The vessel was then evacuated and back-filled with nitrogen. The resulting reaction mixture was stirred at 85° C. for 18 hours, after 3 hours additional Pd(dppf)Cl2.DCM and CuI was added. The mixture was cooled to room temperature and partitioned between EtOAc and sat. aqueous solution of ammonium chloride. The organic layer was washed with water, brine, dried over Na2SO4, filtered and concentrated in vacuo. The residue was purified by column chromatography (cyclohexane:EtOAc, 20-70%) affording 4-(2-Chloro-9-methyl-6-morpholin-4-yl-9H-purin-8-yl)-piperidine-1-carboxylic acid tert-butyl ester as a solid (375 mg, 33%). LCMS (Method H): RT 4.57 min, [M+H]+ 437.46 1H NMR (400 MHz, CDCl3): δ 4.40-4.15 (m, 6 H); 3.81 (t, J=12.1 Hz, 4 H); 3.71 (s, 3); 2.99-2.87 (m, 3 H); 1.94-1.85 (m, 4 H); 1.71-1.59 (m, 1 H); 1.48 (s, 9H).

後処理

  1. additionwas added
  2. additiona 7:5 (v:v) mixture of TMS-C1
  3. stirringthe reaction mixture was stirred for 30 minutes at room temperature
  4. filtrationThe zincate mixture was quickly filtered through a grade-3 sintered funnel
  5. customThe vessel was then evacuated
  6. additionback-filled with nitrogen
  7. customThe resulting reaction mixture
  8. temperatureThe mixture was cooled to room temperature
  9. custompartitioned between EtOAc and sat. aqueous solution of ammonium chloride
  10. washThe organic layer was washed with water, brine
  11. dry with materialdried over Na2SO4
  12. filtrationfiltered
  13. concentrationconcentrated in vacuo
  14. customThe residue was purified by column chromatography (cyclohexane:EtOAc, 20-70%)

出典と根拠

ORDレコード
ord-e2a8bac6ad1348edbb45045ca1968798
出典データセット
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08173650B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート